News / Events

Press Releases

Upcoming Events

Past Events

Email Alerts

Press Releases

First | Previous | Next  | Last

IR Calendar of Events

9

July

2025

Application Update Based on Extensive Review of DataGLEN ALLEN, Va., July 09, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) ("Adial" or the "Company"), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and...
25

June

2025

Scope of Agreement with Cambrex to Provide Ondansetron HCL Drug Substance Under FDA Approved Drug Master File Scope Of Agreement With Thermo Fisher to Provide Manufacturing Services Including Demonstration, Clinical, Registration And Validation Batches of AD04 for US Clinical Trials And NDA Submiss...
17

June

2025

GLEN ALLEN, Va., June 17, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) ("Adial" or the "Company"), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today announced the pricing of i...
16

June

2025

End of Phase 2 Meeting has been Rescheduled for July 29th Meeting to Discuss Upcoming Clinical Development Plan and Protocol Designs Strategic Partnership Discussions Expected to Accelerate Following a Positive FDA Meeting GLEN ALLEN, Va., June 16, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals...
11

June

2025

Engages with Cytel's Machine Learning Technology on Data Analysis and Phase 3 Trial DesignGLEN ALLEN, Va., June 11, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) ("Adial" or the "Company"), a clinical-stage biopharmaceutical company focused on deve...
First | Previous | Next  | Last

Upcoming Events

There are currently no events to display.

Past Events

Adial Pharmaceuticals to Present at the 2024 ThinkEquity Conference
10/30/2024 08:30 AM Eastern

H.C. Wainwright 26th Annual Global Investment Conference
9/9/2024 

Sign Up for Email Alerts

Please fill out the form below to receive company press releases via email when they occur.